Please login to the form below

Aplidin

This page shows the latest Aplidin news and features for those working in and with pharma, biotech and healthcare.

abaloparatide) and confirming its earlier rejection of Pharma Mar’s Aplidin (plitidepsin) as a treatment for multiple myeloma.

Promising new agents for multiple myeloma

Other anti-cancer agents. Plitidepsin (Aplidin; PharmaMar) induces cell death through various cellular pathways.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Add my company

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Solaris Health looks at the gene therapy revolution: Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...